ZYUS Life Sciences Corp. Celebrates Listing on TSX Venture Exchange

Finance
Written By VS BRANDS

ZYUS Life Sciences Corp. Closes the Market Wednesday, July 19, 2023

Toronto, July 19, 2023 (VSNewsNetwork.com) - ZYUS Life Sciences Corp. (TSXV: ZYUS) marked its listing on the TSX Venture Exchange with a market close ceremony. Led by Brent Zettl, President and CEO of ZYUS, and his team, the company is dedicated to revolutionizing the treatment of chronic and neuropathic pain through cannabinoid formulations. ZYUS aims to transform pain management through scientific discovery, clinical research, and the development of pharmaceutical drug products that harness the therapeutic potential of cannabinoids. The company is committed to protecting its novel cannabinoid-based therapies through intellectual property activities.

Source: Toronto Stock Exchange

VS BRANDS https://linktr.ee/vsbrands
Previous

Decisive Dividend Corporation Acquires Innovative Heating Technologies Inc. and Expands Credit Facilities
Next

WildBrain Completes House of Cool Acquisition, Expanding Pre-Production Capabilities